GF Fund Management
TWST icon

GF Fund Management’s Twist Bioscience TWST Stock Holding History

GF Fund Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$204K Sell
1,055
-245
-19% -$30.3K ﹤0.01% 273
2026
Q2 		$134K Sell
1,300
-73
-5% -$4.75K ﹤0.01% 305
2026
Q1 		$65.2K Buy
1,373
+172
+14% +$7.71K ﹤0.01% 372
2025
Q4 		$38.1K Sell
1,201
-98
-8% -$3.06K ﹤0.01% 431
2025
Q3 		$36.6K Sell
1,299
-221
-15% -$6.69K ﹤0.01% 426
2025
Q2 		$55.9K Hold
1,520
– – ﹤0.01% 404
2025
Q1 		$59.7K Buy
1,520
+274
+22% +$12.3K ﹤0.01% 403
2024
Q4 		$57.9K Buy
+1,246
New +$56.3K ﹤0.01% 376

Other funds holding TWST

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

GF Fund Management's TWST Position: Q3 2026 in Review

GF Fund Management reduced its Twist Bioscience (TWST) stake by 19% in Q3 2026, selling an estimated $30.3K and leaving 1,055 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #273.

GF Fund Management first reported a position in TWST in Q4 2024 and has held it in 8 quarters since. 166 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

  • GF Fund Management held 1,055 shares of Twist Bioscience worth $204K as of Q3 2026.
  • GF Fund Management sold 245 Twist Bioscience shares in Q3 2026, an estimated $30.3K.
  • Twist Bioscience made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #273 holding.
  • GF Fund Management first reported a position in Twist Bioscience in Q4 2024 and has held it in 8 quarters since.
  • 166 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.